#who #hepatitisb #guidelines
In a landmark move, the World Health Organization (WHO) has released groundbreaking guidelines to address the global challenge of chronic hepatitis B (HBV) infection. Unveiled at the 2024 Asian Pacific Conference for the Study of Liver Disease in Kyoto, Japan, these guidelines aim to simplify and expand access to HBV testing and treatment, marking a crucial step towards the WHO's goal of eliminating viral hepatitis by 2030. \. With over 250 million people worldwide living with HBV, the new WHO guidelines focus on preventing mother-to-child transmission, a key transmission route, by recommending antiviral treatment for pregnant women and immediate newborn vaccination. This approach not only aims to reduce the global burden of HBV but also prevents liver-related complications, aligning with India's efforts to curb the disease through its Universal Immunization Program (UIP). Additionally, they focus on improving HBV diagnostics, addressing hepatitis delta coinfection, and enhancing the delivery of HBV services to ensure long-term adherence to therapy and retention in care.
Check full updates on Medical Dialogues
Also check out -
Medical Dialogues Academy, a renowned academic wing of Medical Dialogues - India's premier health and news online portal, proudly presents this comprehensive course tailored for healthcare professionals eager to delve into the realm of medical journalism.
🔗 Enroll Today: [ Ссылка ]
📚 Explore More With Us:
📌 Medical Content Writing: [ Ссылка ]
📌 Certificate Course in Pharmaceutical Medico-Marketing: [ Ссылка ]
Join us on this enlightening journey and become a part of a community pushing the boundaries of healthcare communication and reporting.
Get the latest medical and health news at medicaldialogues.in
Follow us on
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
LinkedIn: [ Ссылка ]
Website: [ Ссылка ]
![](https://i.ytimg.com/vi/EKxQrslYIWQ/maxresdefault.jpg)